From the editor

Article

Happy New Year to you all and welcome to the second edition of Ophthalmology Times Europe.

This issue sees us ask the question "Will phakic IOL implantation become the procedure of choice for certain forms of refractive correction?" Some experts believe so and this month we are fortunate enough to relay to you the opinions, knowledge and experience of several refractive specialists. With each tackling various issues relating to phakic IOL use, is the evidence presented here compelling enough for you to tout the new generation of refractive lenses as a force to be reckoned with? Could you convince your patients to accept this form of refractive correction, despite current perceptions? Read on and form your own opinions.

Elsewhere, we focus on advances in the ever-changing area of corneal surgery. Massimo Busin describes a new method of microkeratome-assisted penetrating keratoplasty that does not require endothelial transplantation for advanced keratoconus - a study that gained him an award for a "Best National Paper on Ophthalmology" from the World Ophthalmology Congress 2006. Meanwhile, Daljit Singh describes a new method, which could eliminate the need for corneal transplants in certain cases. Also in this issue, we present some recent advances and cutting edge discoveries in the areas of cataract surgery and glaucoma treatment, designed to intrigue and enthuse you.

As always, I would be delighted to hear what you have to say so please do let me know what you think of Ophthalmology Times Europe, what you like, what you don't like and, most importantly, how we can serve you better. Why not stop by at the World Ophthalmology Congress in SãPaulo and speak with us personally. Alternatively, please direct any feedback to fpavlou@advanstar.com

I look forward to hearing from you.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.